Introduction
The gut-brain axis reflects the interactions between the gastrointestinal system and the brain in general. This physiological system is an artificial dissection from the integrative physiological system that balances the interaction between the individual organs in the body in response to external and internal changes. It is crucial to appreciate the current concepts of this system to understand the gut-brain interaction.
General concepts of the gut-brain axis
Classical endocrine organs, like the pituitary, thyroid, pancreatic islets, adrenals, and the gonads, produce hormones that are transported by the blood to exert their effects on distant organs through specific receptors. However, it has become evident that not only these organs but also all other organs produce hormones. Therefore, all organs communicate with each other through the secretion of specific hormones, exerting distant effects depending on the expression of the appropriate receptors.
The integrative physiology of the body is not only maintained by this complex system of classical and nonclassical hormones but also by the two-way interaction between the central nervous system and peripheral organs through the activity of the autonomous nervous system. This system consists of two, neuronanatomically distinct, pathways, the sympathetic and the parasympathetic nervous system, which have in general opposite effects. The balance between the activities of these two branches of the autonomous nervous system determines the ultimate effects on the organ of interest. Consequently, integrative physiology of the body is maintained by the complex interactions in each organ between this endocrine, blood-borne system on one hand and the dual autonomous nervous system on the other. These endocrine and neural systems interact both at the levels of the brain and the peripheral organs ( Fig. 1 ). In the brain, hormones inform the brain of the status of the organs of origin of the hormone of interest through the activation of specific brain receptors. This will modulate complex pathways and ultimately affect functions of distant organs through the effects of the central and peripheral autonomic nervous system. In turn, the activity of the autonomous nervous system is a major determinant of hormone secretion by organs and also tissue-specific hormone sensitivity.
Purpose of review
To summarize recent studies on the regulation and the functions of the gut-brain axis.
Recent findings
Visual cues of food and food intake interact with the gut-brain axis at the level of the hypothalamus. However, the hypothalamic response to glucose intake is considerably altered in patients with type 2 diabetes mellitus, indicating involvement of the hypothalamus in the pathophysiology of this disease in humans. A large number of studies have documented the functions of gut peptides with respect to the regulation of satiety. Gut peptides are involved in the regulation of insulin secretion and sensitivity. Recent data indicate that peptide YY is a gut hormone that also modulates bone metabolism. Increasing evidence is obtained on the role of afferent gastrointestinal nerves, especially the vagal nerve, in the modulation of the functions of the gut-brain axis.
Summary
The gut-brain axis is involved in a multitude of physiological processes including satiety, food intake, regulation of glucose and fat metabolism, insulin secretion and sensitivity and bone metabolism. It is likely, that more aspects of this system will be found the near future.
Keywords bone, functional MRI, gut peptides, hypothalamus, insulin sensitivity, neuropeptide Y, peptide YY, sympathetic nerves, type 2 diabetes mellitus, vagal nerve These general concepts of integrative physiology also apply to the so-called gut-brain axis. The brain receives both neural and endocrine inputs from the gut in response to food intake, which are integrated with signals from other organs to orchestrate physiological responses. We define the gut-brain axis to encompass all, including afferent and efferent neural, endocrine, and nutrient signals between the central nervous system and the gastrointestinal system. Major integrating centers within the brain are the hypothalamic nuclei. In this study, we will consider recent publications on the different functions of the gut-brain axis.
Visualization of the gut-brain axis in humans upon challenge by visual cues and glucose
The visual perception of food is a key signal for the incentive to eat and is associated with the activation of specific brain areas. There is interaction between external visual cues and the homeostatic regulation of food intake, reflected by hypothalamic activation in response to visual food stimuli measured by functional MRI [1]. Functional MRI measures the local changes in blood flow that accompanies changes in neuronal activity. We interpret these observations that visual cues are likely to interact with the gut-brain axis at the level of the hypothalamus.
Recent studies have also measured hypothalamic activity upon ingestion of food and upon administration of gut hormones (see below) by functional MRI. In healthy individuals, glucose ingestion resulted in a prolonged significant blood oxygen level-dependent signal decrease in the upper and lower hypothalamus in healthy individuals, reflecting inhibition of neuronal activity. In contrast, this inhibitory effect of glucose ingestion was absent in patients with type 2 diabetes mellitus. This suggests that hypothalamic neurons of patients with type 2 diabetes erroneously perceive and/or process endocrine cues originating from the ingestion of glucose. As the gut-brain axis coordinates metabolic and behavioral adaptations in response to these cues to maintain energy balance, hypothalamic dysfunction may hamper postprandial insulin action and compromise satiety in patients with type 2 diabetes [2 ].
Gut hormones
Many peptides are secreted by the gastrointestinal system and transported by the blood to the brain. Drugs mimicking glucagon like peptide-1 (GLP-1) or inhibiting the catabolism of this hormone have been introduced for the treatment of type 2 diabetes mellitus because they lower plasma glucose levels through complex mechanisms including increased glucose-induced insulin secretion. For information on GLP-1 and the clinical applications of the GLP-1 system, we refer to recent extensive reviews [3, 4] . Major other gastrointestinal peptides include cholecystokinin (CCK), oxyntomodulin, ghrelin, and peptide YY (PYY) (reviewed in [5 ] ). The currently known specter of gut-derived hormones is likely to be incomplete. In addition, to GLP-1, PYY has received considerable attention recently. Therefore, we focus on this gut peptide. In addition we focus on the metabolic effects of gut peptides.
Peptide YY
PYY is released from the gut postprandially and transported to the brain by crossing the semipermeable blood-brain barrier in the arcuate nucleus. In the brain, PYY3-36 can bind to the Y2 receptor, an inhibitory presynaptic receptor expressed by neuropeptide Y (NPY) neurons in the hypothalamic arcuate nucleus. PYY3-36 can also bind to Y2 receptors associated with the afferent fibers in the vagal nerve, which, in turn, projects on the arcuate nucleus. Within the arcuate nucleus, two opposing neuronal circuits are involved in the regulation of food intake: the AgRP/NPY system, which stimulates food intake, and the pro-opiomelanocortin/alpha melanocyte stimulating hormone (POMC/ alpha MSH) system, which inhibits food intake [6] [7] [8] . PYY overexpressing mice are protected from dietinduced obesity [9] . Conversely, daily food intake, body weight, and fat content are increased in PYY knockout mice compared with wild-type mice [10] , although in another study only mild changes were seen on a high-fat
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Figure 1 A general outline of the gut-brain axis
The gut communicates with the rest of the body through nutrients absorbed by the gut, peptides secreted by the gut to the blood and activation of afferent (para) sympathetic nerves. The central nervous system integrates these signals, especially at the level of the hypothalamus and responds through alterations in satiety and altered regulation of metabolism. Peripheral tissues are influenced by the nutrients and the gut hormones, and also by the alterations in autonomous nervous activity induced by the effects of the gut -brain axis at the level of the brain. diet but not on a show diet in mice [11 ] . Infusion of PYY reduces food intake in rodents and humans [12] . However, although subcutaneous administration of PYY is well tolerated, it remains to be determined whether high-dose PYY(3-36) is sufficient in reducing energy intake in long-term trials, and if so, whether the reduction in energy intake occurs without nausea. PYY(1-36) is unlikely to be important in regulating energy intake [13] . Therefore, many uncertainties remain with respect to the therapeutical efficacy of PYY derivatives [14 ] . Drugs have also been developed, which selectively activate the NPY2 receptor, which induced a dose-dependent reduction in food intake in lean mice and in food intake, body weight, and fat mass in diet-induced obese (DIO) mice [15] .
Using functional MRI in humans, Batterham et al. [16 ] recently showed that PYY(3-36) modulates neural activity within corticolimbic and higher cortical areas as well as homeostatic brain regions. Under conditions of high plasma PYY concentrations induced by PYY infusion, mimicking the fed state, changes in neural activity within the caudolateral orbital frontal cortex predicted feeding behavior independently of meal-related sensory experiences. In contrast, in conditions of low levels of PYY, hypothalamic activation predicted food intake. Therefore, they concluded that the presence of a postprandial satiety factor switches food intake regulation from a homeostatic to a hedonic, corticolimbic area.
PYY has also been studied in combination with GLP-1 after gastric bypass surgery for the treatment of obesity. The altered gastrointestinal anatomy in these patients results in changes in appetite within days after surgery, associated with increased levels of PYY and GLP-1. Conversely, appetite returns in these patients when the secretion of these hormones is inhibited by somatostatin [17] . These results implicate that these gut hormones are involved in weight loss after gastric bypass surgery. Nonetheless, there are also contrasting observations. For instance, in obese individuals weight loss was associated with a major decrease in PYY levels, whereas weight gain had no effect on fasting PYY levels in individuals with anorexia. Moreover, PYY levels did not differ between lean and obese individuals [18] .
Nonsatiety effects of gut hormone
Most studies have focused on the effects of gut hormones on satiety and body weight regulation. However, in recent years, it has become evident that these gut peptides have also major effects on metabolic regulation. For instance, PYY also increases fat oxidation and insulin sensitivity, especially of insulin-mediated glucose disposal in mice. These effects persist even during chronic treatment [19 ] . In humans, PYY caused increased plasma levels of glucose, insulin, and free fatty acid (FFA) [13, 20] .
Another remarkable observation was that PYY regulates bone turnover in rats. In Pyy À/À mice, the most important physiological role of endogenous Pyy may lie in the control of bone remodeling, because Pyy À/À mice exhibit a substantial reduction in trabecular bone mass, resulting in decreased bone strength [11 ] . This observation is in line with the observation that hypothalamic Y2 receptors may play a key role in a major central regulatory circuit of bone formation [21] .
Therefore, the gut-brain axis is involved in the integrative physiological regulation of many complex processes involving satiety, food intake, regulation of glucose and fat metabolism, hormone sensitivity (e.g., insulin sensitivity), and bone metabolism. It is likely that more aspects of this system will be found.
The role of vagal nerves in the gut-brain axis
Information from the intestinal mucosa is not only conveyed through the abovementioned endocrine pathways but also through afferent pathways in vagal and spinal afferent nerves to nucleus tractus solitarius, arcuate nucleus, and thalamic center of satiety [22] . Stimulation of these afferent vagal nerves decreases food intake, gastric emptying, and stimulation of pancreatic secretion. It appears that these afferent nerves start very close to the basolateral membrane of enteroendocrine cells, but they do not reach the lumen of the gut [23] . Remarkably, vagal nerves consist predominantly of afferent and only for a very small extent of efferent fibers [24] . It is assumed that afferent nerves are not directly activated by luminal contents but by regulatory paracrine factors released by the enterocytes. Recent studies indicate that CCK and serotonin (5-hydroxytryptamine, 5-HT) act through vagal afferent fibers to mediate gastrointestinal functions [25] . In addition, vagal afferent neurons are activated by leptin, and this activation is likely to participate in meal termination, perhaps by enhancing vagal sensitivity [26] . The studies published sofar are consistent with a significant decrease in body mass during vagal stimulation [27] . Therefore, vagal stimulation may be an interesting approach to reduce food intake and weight.
Conclusion
The gut-brain axis represents the complex interactions between the gut and the brain, involving nutrients, hormones, and afferent/efferent regulatory autonomous neural pathways. This gut-brain axis is involved in a multitude of physiological processes including satiety, food intake, regulation of glucose and fat metabolism, hormone secretion and sensitivity (especially insulin sensitivity), and bone metabolism. It is likely that more aspects of this system will be found in the near future.
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